MicroRNA electrochemical biosensors for pancreatic cancer

F Rahdan, F Bina, EN Dolatabadi, D Shaterabadi… - Clinica Chimica …, 2023 - Elsevier
Pancreatic cancer (PC) is one of the deadliest cancers worldwide. MicroRNAs (miRs) are
sensitive molecular diagnostic tools that can serve as highly accurate biomarkers in many …

Recent developments of nanomedicine delivery systems for the treatment of pancreatic cancer

N Rezaei, M Shahriari, F Mehrnejad - Journal of Drug Delivery Science and …, 2023 - Elsevier
Pancreatic cancer (PCa) is one of the principal causes of death from cancer, resulting in a
low patient survival rate due to its late diagnosis. Many factors are involved in the failure of …

[HTML][HTML] AUM302, a novel triple kinase PIM/PI3K/mTOR inhibitor, is a potent in vitro pancreatic cancer growth inhibitor

K Ingle, JF LaComb, LM Graves, AT Baines… - PLoS …, 2023 - journals.plos.org
Pancreatic cancer is one of the leading causes of cancer deaths, with pancreatic ductal
adenocarcinoma (PDAC) being the most common subtype. Advanced stage diagnosis of …

[HTML][HTML] Polyethyleneglycol-Betulinic Acid (PEG-BA) polymer-drug conjugate induces apoptosis and antioxidation in a biological model of pancreatic cancer

KS Mosiane, EE Nweke, M Balogun, PN Fru - Polymers, 2023 - mdpi.com
Pancreatic cancer (PC) is one of the most aggressive solid malignancies with poor treatment
response and low survival rates. Herbal medicines such as betulinic acid (BA) have shown …

[HTML][HTML] Gemcitabine and rapamycin-loaded mixed polymeric thermogel for metastatic pancreatic cancer therapy

SY Kim, MJ Jo, MS Yoon, CE Jin, YB Shin… - Journal of Controlled …, 2023 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC) is the 4th leading cause of cancer–related death
and has a poor 5–year overall survival. The superior therapeutic benefits of combination or …

[HTML][HTML] Earlier Diagnosis of Pancreatic Cancer: Is It Possible?

T Koltai - Cancers, 2023 - mdpi.com
Simple Summary Pancreatic cancer incidence is increasing yearly. The reasons are not well
known. Unfortunately, this is one of the least treatable cancers. Standard chemotherapy …

[HTML][HTML] Prognostic evaluation of pancreatic cancer based on the model of chemo-radiotherapy resistance-related genes

H Sun, W Zhang, Y Chu, L Zhou, F Gong… - Journal of …, 2023 - ncbi.nlm.nih.gov
Background The incidence and mortality of pancreatic cancer are almost the same, and the
5-year survival rate is less than 10%. The high mortality of pancreatic cancer is related to …

[HTML][HTML] Glucose Regulation after Partial Pancreatectomy: A Comparison of Pancreaticoduodenectomy and Distal Pancreatectomy in the Short and Long Term

JS Lee, M Sohn, K Kim, YS Yoon… - Diabetes & Metabolism …, 2023 - ncbi.nlm.nih.gov
Background Long term quality of life is becoming increasingly crucial as survival following
partial pancreatectomy rises. The purpose of this study was to investigate the difference in …

[HTML][HTML] Systemic diseases and gastrointestinal cancer risk

N Malkani, MU Rashid - Journal of Cancer & Allied Specialties, 2023 - ncbi.nlm.nih.gov
Importance: Gastrointestinal (GI) cancers are the second leading cause of cancer-related
deaths worldwide. Observations: The global challenges GI cancers pose are high …

Integrated in silico analysis of proteogenomic and drug targets for pancreatic cancer survival

A Bera, D Chatterjee, J Hester, M Srivastava - Cancer Systems and …, 2023 - Springer
Pancreatic cancer remains a major health concern, being among the deadliest forms of
cancer with over 80% of the patients presenting with metastatic disease. According to the …